Companies

Dr.Reddy’s launches OTC eye care solution in US market

Our Bureau Hyderabad | Updated on September 17, 2020 Published on September 17, 2020

The olopatadine hydrochloride ophthalmic solution is for temporary relief of itchy eyes

Dr.Reddy’s Laboratories has announced the launch of its over-the-counter (OTC) olopatadine hydrochloride ophthalmic solution in the US market as approved by the US Food and Drug Administration (USFDA).

Solution USP 0.2% and 0.1% are indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander. USP 0.1% is also indicated for the temporary relief of red eyes.

Why Dr Reddy’s remains a good long-term bet despite recent rally

“This launch marks the entry of Dr.Reddy’s into the OTC eye care space, and is a testament to our deep capabilities in bringing store-brand equivalents of Rx-to-OTC switches to the US market,” says Marc Kikuchi, CEO, North America Generics, Dr.Reddy’s Laboratories. “We are very excited to extend our strategic collaboration with Gland Pharma to bring these products to the market. We thank the teams at Gland and Dr.Reddy’s, whose hard work and efforts have enabled the execution of this launch in such a short time frame.”

Dr Reddy’s to launch 25 products in US this fiscal

Dr.Reddy’s olopatadine hydrochloride ophthalmic solution USP 0.2% is available in a 2.5-ml bottle and USP 0.1% in 5-ml bottle size.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on September 17, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.